pro 2014 (2014 version; treeage 40 cese-pgs version 1.0 03/07/2017 software) (treeage software)
90
Structured Review
treeage software
pro 2014 (2014 version; treeage 40 cese-pgs version 1.0 03/07/2017 software)
Pro 2014 (2014 Version; Treeage 40 Cese Pgs Version 1.0 03/07/2017 Software), supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pro+2014+software/tree+age+pro+2015/pmc10988349__jamanetwopen___e244438___s001-498-10-15
Average 90 stars, based on 1 article reviews
Pro 2014 (2014 Version; Treeage 40 Cese Pgs Version 1.0 03/07/2017 Software), supplied by treeage software, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/pro+2014+software/tree+age+pro+2015/pmc10988349__jamanetwopen___e244438___s001-498-10-15
Average 90 stars, based on 1 article reviews
pro 2014 (2014 version; treeage 40 cese-pgs version 1.0 03/07/2017 software) - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
Software:Article Title: Cost-effectiveness of the highly effective direct-acting antivirals in the treatment of chronic hepatitis C in Hong Kong. Article Snippet: Declaration of conflict of interest: Angeline Lo declares that she has no competing interests.. Henry Chan is a consultant for Bristol-Myers Squibb, Gilead, Merck, Novartis, and Roche, has received honorarium for lecture for Abbott, Abbvie, Bristol-Myers Squibb, Echosens, Gilead, Glaxo-Smith-Kline, Merck, Novartis, and Roche, and has received an unrestricted grant from Roche for hepatitis B research.Vincent Wong has served as an advisory committee member for Abbvie, Roche, Novartis, Gilead, and Otsuka as well as a speaker for Abbvie, Bristol-Myers Squibb, Roche, Novartis, Abbott Diagnostics, and Echosens.Grace Wong has served as an advisory committee member for Otsuka and Gilead as well as a speaker for Abbott, Abbvie, Bristol-Myers Squibb, Echosens, Furui, Gilead, Janssen, Otsuka, and Roche.. Author contributions: All authors have full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Article Title: An empirical comparison of Markov cohort modeling and discrete event simulation in a capacity-constrained health care setting. Article Snippet: .. The MM was developed in Article Title: Cost-Effectiveness Analysis of Deep Brain Stimulation in Patients with Parkinson's Disease in Japan. Article Snippet: Accepted Manuscript Cost-effectiveness analysis of deep brain stimulation in patients with Parkinson’s disease in Japan Yukiyoshi Kawamoto, Mitsuko Mouri, PhD, Takaomi Taira, MD, PhD, Hiroshi Iseki, MD, PhD, Ken Masamune, PhD PII: S1878-8750(15)01663-0 DOI: 10.1016/j.wneu.2015.11.062 Reference: WNEU 3461 To appear in: World Neurosurgery Received Date: 15 August 2015 Revised Date: 10 November 2015 Accepted Date: 12 November 2015 Please cite this article as: Kawamoto Y, Mouri M, Taira T, Iseki H, Masamune K, Cost-effectiveness analysis of deep brain stimulation in patients with Parkinson’s disease in Japan, World Neurosurgery (2016), doi: 10.1016/j.wneu.2015.11.062.. This is a PDF file of an unedited manuscript that has been accepted for publication.. As a service to our customers we are providing this early version of the manuscript. Article Title: Hematopoietic Stem-Cell Transplantation versus Immunosuppressive Therapy in Patients with Adult Acquired Severe Aplastic Anemia: A Cost-Effectiveness Analysis Article Snippet: We used TreeAge Pro 2011 software to build the Markov model to assess the cost-effectiveness of the two options. .. Article Title: Cost-effectiveness analysis of infliximab, adalimumab, golimumab and vedolizumab for moderate to severe ulcerative colitis in Spain. Article Snippet: Objectives Assess the efficiency of biologic treatment for moderate to severe ulcerative colitis (UC) which are indicated and financed for this pathology by Spain.. Methods A Markov model was constructed to simulate the progression in a cohort of patients with moderate to severe UC.. The perspective chosen was National Health Service with an over 10 years of time horizon, with a discount rate of 3%, and established threshold of €30,000/quality-adjusted life-year (QALY). Article Title: Network meta-analysis and cost-effectiveness analysis of infliximab, cyclosporine and tacrolimus for ulcerative colitis Article Snippet: .. The calculation was conducted using Article Title: Induction of Labor versus Scheduled Cesarean in Morbidly Obese Women: A Cost-Effectiveness Analysis. Article Snippet: 1Division of Maternal and Fetal Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 2Division of Maternal and Fetal Medicine, Duke University Medical Center, Durham, North Carolina 3Division of Clinical and Epidemiologic Research, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 4Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina other:Article Title: Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model. Article Snippet: Estimating potential for savings for low risk endometrial cancer using the Endometrial Cancer Alternative Payment Model (ECAP): A companion paper to the Society of Gynecologic Oncology Report on the Endometrial Cancer Alternative Payment Model Jason D. Wright , Laura J. Havrilesky , David E. Cohn , Yongmei Huang , Jill Rathbun , Laurel W. Rice , Carol L. Brown , Ronald D. Alvarez , Emily M. Ko h,⁎ Modification:Article Title: Induction of Labor versus Scheduled Cesarean in Morbidly Obese Women: A Cost-Effectiveness Analysis. Article Snippet: 1Division of Maternal and Fetal Medicine, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania 2Division of Maternal and Fetal Medicine, Duke University Medical Center, Durham, North Carolina 3Division of Clinical and Epidemiologic Research, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, North Carolina 4Division of Gynecologic Oncology, Duke University Medical Center, Durham, North Carolina |